|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―May―12 |
Genomic characteristics of SARS-CoV-2 in Beijing, 2021 |
Zhaomin Feng, Shujuan Cui, Bing Lyu, Zhichao Liang, Fu Li, Lingyu Shen, et al. (+5) Hui Xu, Peng Yang, Quanyi Wang, Daitao Zhang, Yang Pan |
2 |
[GO] |
2022―May―07 |
Screening for inhibitors against SARS-CoV-2 and its variants |
Weijing Yuan, Xiaojing Dong, Lan Chen, Xiaobo Lei, Zhuo Zhou, Li Guo, Jianwei Wang |
3 |
[GO] |
2022―May―05 |
Application of animal models to compare and contrast the virulence of current and future potential SARS-CoV-2 variants |
Zhe Ding, Tong Chen, Jiaming Lan, Gary Wong |
4 |
[GO] |
2022―Apr―28 |
An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses |
Hao Lin, Jie Zhang, Shaobo Dong, Yaning Liu, Peipei Liu, George F. Gao, et al. (+2) William J. Liu, Guizhen Wu |
5 |
[GO] |
2022―Apr―25 |
Genetic differentiation and diversity of SARS-CoV-2 omicron variant in Its early outbreak |
Shenghui Weng, Jingzhe Shang, Yexiao Cheng, Hangyu Zhou, Chengyang Ji, Rong Yang, Aiping Wu |
6 |
[GO] |
2022―Apr―19 |
Importation of SARS-CoV-2 omicron variant in beijing, china |
Fu Li, Zhichao Liang, Shujuan Cui, Bing Lv, Zhaomin Feng, Hui Xu, et al. (+5) Lei Jia, Peng Yang, Quanyi Wang, Yang Pan, Daitao Zhang |
7 |
[GO] |
2022―Apr―12 |
Case report: Long-term asymptomatic SARS-CoV-2 infection associated with deficiency on multiple immune cells |
Gang He, Xia Chuai, Dan Liang, Chunyu Chen, Changzheng Hu, Changwen Ke, et al. (+3) Bixia Ke, Peilin Zhen, Huajun Zhang |
8 |
[GO] |
2022―Mar―04 |
Cell-cell communication analysis for single-cell RNA sequencing and its applications in carcinogenesis and COVID-19 |
Md Wahiduzzaman, Yuexing Liu, Tao Huang, Wu Wei, Yixue Li |
9 |
[GO] |
2022―Jan―19 |
Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health |
Zepeng Xu, Kefang Liu, George F. Gao |
10 |
[GO] |
2022―Jan―04 |
Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles |
Sheng Wang, Lizhen Liu, Can Wang, Ziqiang Wang, Xuhua Duan, Gang Chen, et al. (+2) Hu Zhou, Hong Shao |
11 |
[GO] |
2021―Dec―28 |
Laboratory biosafety measures of SARS-CoV-2 at containment level 2 with particular reference to its more infective variants |
Wafa Naeem, Habiba Zeb, Muhammad Ibrahim Rashid |
12 |
[GO] |
2021―Dec―25 |
Lack of evolutionary changes identified in SARS-CoV-2 for the re-emerging outbreak of COVID-19 in Beijing, china |
Yang Li, Yunjun Zhang, Mifang Liang, Yi Zhang, Xuejun Ma, Yong Zhang, Xiaohua Zhou |
13 |
[GO] |
2021―Dec―25 |
Forecasting COVID-19 situation in Bangladesh |
Mossamet Kamrun Nesa, Md. Rashed Babu, Mohammad Tareq Mamun Khan |
14 |
[GO] |
2021―Nov―14 |
Sirolimus Combined with Oseltamivir and Corticosteroid Treatment for a Puerpera with Severe Pneumonia Caused by 2009 Pandemic H1N1:A Case Report |
Lijun Suo, Xiaofeng Yu, Yongfeng Hu, Hongyun Cao, Xiaohui Zou, Peiquan Wang, et al. (+6) Tao Xu, Xiangzhi Zhou, Yexin Wu, Lili Ren, Bo Liu, Bin Cao |
15 |
[GO] |
2021―Sep―13 |
Evaluating the effectiveness of control measures in multiple regions during the early phase of the COVID-19 pandemic in 2020 |
Zengmiao Wang, Jason Whittington, Hsiang-Yu Yuan, Hui Miao, Huaiyu Tian, Nils Chr. Stenseth |
16 |
[GO] |
2021―Sep―09 |
The impact of Sample Processing on the Rapid Antigen Detection test for SARS-CoV-2: Virus Inactivation, VTM Selection, and Sample Preservation |
Haiwei Zhou, Conghui Wang, Jian Rao, Lan Chen, Tingting Ma, Donglai Liu, et al. (+2) Lili Ren, Sihong Xu |
17 |
[GO] |
2021―Aug―27 |
Expression pattern and function of SARS-CoV-2 Receptor ACE2 |
Rui-Ting Li, Cheng-Feng Qin |
18 |
[GO] |
2021―Aug―12 |
Environmental factors and their role in the transmission of SARS-CoV-2 |
Dawid Maciorowski, Divakar Sharma, Adinarayana Kunamneni |
19 |
[GO] |
2021―Jul―21 |
SARS-CoV-2 Spike Protein and RNA Dependent RNA Polymerase as Targets for Drug and Vaccine Development: A Review |
Yusuf Muhammed, Abduljalal Yusuf Nadabo, Mkpouto Pius, Bashiru Sani, Jafar Usman, Nasir Anka Garba, et al. (+5) Ja'afaru Mohammed Sani, Basit Opeyemi Olayanju, Sunday Zeal Bala, Musa Garba, Misbahu Sambo |
20 |
[GO] |
2021―Jul―06 |
Surveillance of enteric pathogens in imported seafood and environmental surfaces in five seafood markets before the outbreak of COVID-19 |
Songzhe Fu, Wei Wang, Qingyao Wang, Fenglan He, Jingwei Hao, Bo Pang |
21 |
[GO] |
2021―Jun―04 |
Current knowledge of COVID-19: advances, challenges and future perspectives |
Yuhan Wu, Zhuobing Peng, Yongxue Yan, Jintao Hu, Yalong Wang, Xiaoyu Wang, et al. (+3) Ruchao Peng, Daniel Watterson, Yi Shi |
22 |
[GO] |
2021―Jun―01 |
Virology features of a family cluster of SARS-CoV-2 infections in Shanghai, China |
Yanqiu Zhou, Zheng Teng, Hongyou Chen, Xiaoxian Cui, Fanghao Fang, Jiabin Mou, et al. (+2) Hui Jiang, Xi Zhang |
23 |
[GO] |
2021―May―17 |
Comprehensive interactome analysis of the spike protein of swine acute diarrhea syndrome coronavirus |
Qingxing Wang, Yun Luo, Weijuan Shang, Zhengli Shi, Gengfu Xiao, Leike Zhang |
24 |
[GO] |
2021―Apr―30 |
Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations |
Omkar Indari, Budhadev Baral, Kartik Muduli, Ambika Prasad Mohanty, Natabar Swain, Nirmal Kumar Mohakud, Hem Chandra Jha |
25 |
[GO] |
2021―Mar―19 |
Finding the real COVID-19 case-fatality rates for SAARC countries |
Md. Rafil Tazir Shah, Tanvir Ahammed, Aniqua Anjum, Anisa Ahmed Chowdhury, Afroza Jannat Suchana |
26 |
[GO] |
2021―Feb―10 |
An update to monoclonal antibody as therapeutic option against COVID-19 |
Paroma Deb, Md. Maruf Ahmed Molla, K.M. Saif-Ur Rahman |
27 |
[GO] |
2021―Feb―06 |
Genetic diversity and genomic epidemiology of SARS-CoV-2 in Morocco |
Bouabid Badaoui, Khalid Sadki, Chouhra Talbi, Driss Salah, Lina Tazi |
28 |
[GO] |
2021―Jan―29 |
Technical specifications for the environmental monitoring of SARS-CoV-2 in farmers' (trade) markets in China |
|
29 |
[GO] |
2021―Jan―12 |
Review of pharmacologic and immunologic agents in the management of COVID-19 |
Marzuq A. Ungogo, Mustapha Mohammed, Bala N. Umar, Auwal A. Bala, Garba M. Khalid |
30 |
[GO] |
2020―Dec―30 |
Potential dual outbreak of COVID-19 and HFMD among children in Asia-pacific countries in the HFMD-endemic area |
Lina Jiang, Jing Wang, Bin Yu, Chuanyi Ning, Yi Tan |
31 |
[GO] |
2020―Dec―01 |
The COVID-19 pandemics and the relevance of biosafety facilities for metagenomics surveillance, structured disease prevention and control |
Thiago Moreno L. Souza, Carlos Medicis Morel |
32 |
[GO] |
2020―Nov―27 |
Convincing the confidence to conquer COVID-19: From epidemiological intervention to laboratory investigation |
William J. Liu |
33 |
[GO] |
2020―Nov―20 |
Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in destination: Successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface |
Peipei Liu, Mengjie Yang, Xiang Zhao, Yuanyuan Guo, Liang Wang, Jing Zhang, et al. (+6) Wenwen Lei, Weifang Han, Fachun Jiang, William J. Liu, George F. Gao, Guizhen Wu |
34 |
[GO] |
2020―Nov―08 |
Coronavirus COVID- 19: A critical review of its history, pathogenesis, transmission, diagnosis and treatment |
Mohd Sharjeel Sofi, Aadil Hamid, Sami Ullah Bhat |
35 |
[GO] |
2020―Sep―25 |
Facing the 2020 Pandemic: What does Cyberbiosecurity want us to know to safeguard the future? |
Siguna Mueller |
36 |
[GO] |
2020―Sep―23 |
Spatiotemporal patterns and trends of community transmission of the pandemic COVID-19 in South Asia: Bangladesh as a case study |
Ariful Islam, Md Abu Sayeed, Md Kaisar Rahman, Jinnat Ferdous, Shahanaj Shano, Shusmita Dutta Choudhury, Mohammad Mahmudul Hassan |
37 |
[GO] |
2020―Sep―10 |
Estimation of the case fatality rate of COVID-19 epidemiological data in Nigeria using statistical regression analysis |
Ahmad Abubakar Suleiman, Aminu Suleiman, Usman Aliyu Abdullahi, Suleiman Abubakar Suleiman |
38 |
[GO] |
2020―Sep―02 |
Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020 |
Yong Zhang, Yang Pan, Xiang Zhao, Weifeng Shi, Zhixiao Chen, Sheng Zhang, et al. (+8) Peipei Liu, Jinbo Xiao, Wenjie Tan, Dayan Wang, William Jun Liu, Wenbo Xu, Quanyi Wang, Guizhen Wu |
39 |
[GO] |
2020―Sep―02 |
Influenza activity during the outbreak of coronavirus disease 2019 in mainland China |
Mi Liu, Lizong Deng, Dayan Wang, Taijiao Jiang |
40 |
[GO] |
2020―Aug―21 |
Development and effectiveness of Pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro |
Ren Yang, Baoying Huang, A. Ruhan, Wenhui Li, Wenling Wang, Yao Deng, Wenjie Tan |
41 |
[GO] |
2020―Aug―05 |
Tackling COVID-19: Insights from the Qinghai Province Plague Prevention and Control (PPC) model |
Haisheng Wu, Qingwen Zhang, Hailian Wu, Fuzhang Tian, Baizhong Cui, Zhizhen Qi, et al. (+3) Xiaoqing Xu, Xuefei Zhang, Hu Wang |
42 |
[GO] |
2020―Jul―23 |
Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2 |
Yiwei Liu, Yingying Wang, Xinming Wang, Yan Xiao, Lan Chen, Li Guo, et al. (+3) Jianguo Li, Lili Ren, Jianwei Wang |
43 |
[GO] |
2020―Jul―15 |
Epidemiologic and clinical characteristics of 42 deaths caused by SARS-CoV-2 infection in Wuhan, China: A retrospective study |
Nan Zhang, Haochen Yao, Dong Zhang, Jiahui Pan, Ejun Peng, Juanjuan Huang, et al. (+5) Yingli Zhang, Xiaoming Xu, Guobao Tian, Hong Xu, Guoqing Wang |
44 |
[GO] |
2020―Jul―09 |
Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment |
Yusuf Mummed |
45 |
[GO] |
2020―Jul―09 |
Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials? |
Asma Binte Aziz, Jennifer L. Dembinski, Yasmin Jahan |
46 |
[GO] |
2020―May―13 |
Charting the challenges behind the testing of COVID-19 in developing countries: Nepal as a case study |
Anil K. Giri, Divya R.S.B.B. Rana |
47 |
[GO] |
2020―May―12 |
Clinical characteristics of patients diagnosed with COVID-19 in Beijing |
Aihua Jin, Benyong Yan, Wei Hua, Dandan Feng, Bin Xu, Lianchun Liang, Caiping Guo |
48 |
[GO] |
2020―Apr―08 |
Laboratory biosafety guide for 2019-nCoV (Second Edition) |
National Health Commission of the People's Republic of China |
49 |
[GO] |
2020―Apr―02 |
Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy |
Marco D'Arienzo, Angela Coniglio |
50 |
[GO] |
2020―Feb―05 |
Technical guidance for laboratory testing of 2019-nCoV infection (third edition) |
|
51 |
[GO] |
2020―Feb―05 |
A strategy to prevent future pandemics similar to the 2019-nCoV outbreak |
Peter Daszak, Kevin J. Olival, Hongying Li |
52 |
[GO] |
2019―Dec―20 |
A novel luciferase immunosorbent assay performs better than a commercial enzyme-linked immunosorbent assay to detect MERS-CoV specific IgG in humans and animals |
Wenling Wang, Tianyu Wang, Yao Deng, Peihua Niu, A.A. Ruhan, Jincun Zhao, et al. (+3) Malik Peiris, Shixing Tang, Wenjie Tan |